Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer at Sarepta Therapeutics, highlights ASGCT's unique role in bringing together diverse stakeholders and providing evidence-based advocacy to inform cell and gene therapy policy to improve.

Please take the opportunity to connect and share this video with your friends and family if you find it useful.